Richard Sandberg Biography and Net Worth

Director of Precipio

Richard Sandberg, a seasoned diagnostics executive with a substantial track record in the field. Mr. Sandberg brings a wealth of executive experience to the corporate development and strategic direction of Precipio, having founded Dianon Systems, Inc., a leading anatomic pathology laboratory based in Stratford, CT and having served at various times as Chairman, Chief Executive Officer and Chief Financial Officer. Dianon was acquired by Labcorp for $650M in 2002. Mr. Sandberg also serves as Chief Executive Officer of Resolys Bio, Inc, a pharmaceutical company which is developing a pharmaceutical treatment for long-term, chronic traumatic brain injury.

What is Richard A. Sandberg's net worth?: The estimated net worth of Richard A. Sandberg is at least $983.08 thousand as of May 30th, 2025. Mr. Sandberg owns 40,175 shares of Precipio stock worth more than $983,082 as of September 25th. This net worth evaluation does not reflect any other investments that Mr. Sandberg may own. Learn More about Richard A. Sandberg's net worth.
How do I contact Richard A. Sandberg?: The corporate mailing address for Mr. Sandberg and other Precipio executives is 4 Science Park, New Haven CT, 06511. Precipio can also be reached via phone at (203) 787-7888 and via email at [email protected]. Learn More on Richard A. Sandberg's contact information.
Has Richard A. Sandberg been buying or selling shares of Precipio?: Richard A. Sandberg has not been actively trading shares of Precipio over the course of the past ninety days. Most recently, on Friday, May 30th, Richard A. Sandberg bought 1,399 shares of Precipio stock. The stock was acquired at an average cost of $10.00 per share, with a total value of $13,990.00. Following the completion of the transaction, the director now directly owns 40,175 shares of the company's stock, valued at $401,750. Learn More on Richard A. Sandberg's trading history.
Who are Precipio's active insiders?: Precipio's insider roster includes David Cohen (Director), Ilan Danieli (CEO), Ahmed Sabet (COO), and Richard Sandberg (Director). Learn More on Precipio's active insiders.
Are insiders buying or selling shares of Precipio?: In the last year, Precipio insiders bought shares 3 times. They purchased a total of 64 shares worth more than $1,486.17. The most recent insider tranaction occured on April, 1st when COO Ahmed Zaki Sabet bought 19 shares worth more than $530.67. Insiders at Precipio own 16.6% of the company. Learn More about insider trades at Precipio.
Information on this page was last updated on 4/1/2026.

Richard A. Sandberg Insider Trading History at Precipio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2025	Buy	1,399	$10.00	$13,990.00	40,175
5/22/2025	Buy	500	$9.33	$4,665.00	38,675
5/21/2025	Buy	8,035	$9.27	$74,484.45	38,175
5/20/2025	Buy	4,251	$8.47	$36,005.97	30,140
5/19/2025	Buy	714	$8.21	$5,861.94	25,889
11/11/2024	Sell	2,000	$6.28	$12,560.00	16,525
1/20/2023	Buy	1,000	$15.60	$15,600.00	2,042

Richard A. Sandberg Buying and Selling Activity at Precipio

Precipio Company Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Today's Range

Now: $23.97

$24.05

$24.62

50 Day Range

MA: $25.50

$21.19

$31.12

2 Week Range

Now: $23.97

$16.40

$33.63

Volume

22,357 shs

Average Volume

60,637 shs

Market Capitalization

$42.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32